Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 189 results found. Search for [ Dilip Shanghvi ]

Results 1 to 21 of 189
PTI
February 5, 2019



PTI
February 4, 2019



E Kumar Sharma
January 20, 2019
To pinpoint any wrongdoing that Sun Pharma allegedly embarked upon, it is first necessary to get a fix on what the whistle-blower says. Much now depends on what SEBI chooses to do.


Reuters
January 18, 2019
The whistleblower complaint alleges that an Indian pharmaceutical manufacturer Aditya Medisales Ltd had transactions with Suraksha Realty, controlled by Sun Pharma's co-promoter, Sudhir Valia.


PTI
December 26, 2018
Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting Biofrontera defendants from using its confidential and proprietary trade secret information.


E Kumar Sharma
New Delhi, December 18, 2018
Leading Indian pharma company Dr Reddy's has still not been able to overcome the regulatory challenges. Its important Duvvada facility in Andhra has been under warning letter from the US drug regulator since 2015.


PTI
December 13, 2018



PTI
December 13, 2018



PTI
December 13, 2018
Recovery in rupee and positive cues from other Asian markets too influenced investor sentiment. Rising for the third straight session, the 30-share index was trading higher by 263.70 points, or 0.74 per cent, at 36,042.77.


PTI
December 13, 2018



PTI
December 12, 2018



PTI
December 12, 2018



E Kumar Sharma
New Delhi, December 10, 2018
Sun Pharma began the month with shockwaves about irregular practices but is trying to rally after clarifying its stance.


E Kumar Sharma
December 7, 2018
As one corporate leader says: \"We should go by the spirit of the law and not (just) the letter of the law. Good corporate governance does not mean just following the law, but also going beyond and understanding the interests of all stakeholders.\"


BusinessToday.In
December 5, 2018
The BSE SENSEX closed at 35884.41, down by 249.9 points or by 0.69 per cent, and the NSE Nifty ended at 10782.9, down by 86.6 points or by 0.8 per cent.


BusinessToday.In
December 5, 2018
Currently, shares of the company were down 2.04 per cent to trade at Rs 433.75 apiece, on the Bombay Stock Exchange, after opening at Rs 443.00 against a previous closing price of Rs 442.80.


PTI
December 4, 2018



BusinessToday.In
December 4, 2018
Shares of Sun Pharmaceutical Industries rose over 2 per cent in early trade on the Bombay Stock Exchange after the drug maker clarified that it has not been involved in any insider trading norm violations relating to the Ranbaxy deal.


PTI
December 3, 2018



PTI
December 3, 2018



PAGES 1 OF 10  12345